The authors give their 2-year results of a screening programme for the early diagnosis of prostatic cancer. 2723 patients, ranging in age from 45 to 93 years old, have been examined. All men, whose digital rectal examination gave rise to the slightest suspicion of a lesion, were re-examined by TRUS and serum markers. Results have convinced the authors to be sceptical about the clinical utility of this type of prevention.
GerberGD., ChodackGW.: Digital rectal examination in the early detection of prostate cancer. Urol. Clin. North. Am., 17: 739–744, 1990.
2.
ThompsonIM., ZeidmanEJ.: Presentation and clinical course of patients ultimately succumbing to carcinoma of the prostate. Scand. J. Urol. Nephrol., 25: 111–114, 1991.
3.
OesterlinJE.: Prostate specific antigen: a critical assessment of the most useful tumor maker for adenocarcinoma of the prostate. J. Urol., 145: 097–923, 1991.
4.
CatalonaSmith, RafliffDodds, CoplenYuan, PetrosAndriole: Meauserement of prostate specific antingen in serum as a screening test for prostate cancer. N. England J. Med., 324: 1156–1161, 1991.
5.
IversenP., Torp-PedersenS.: Screening for carcinoma of the prostate: sense or non-sens. Current Opinion in Urology, 1: 4–7, 1991.
